[HTML][HTML] Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
J Torresi, D Johnson, H Wedemeyer - Journal of hepatology, 2011 - Elsevier
Hepatitis C virus (HCV) is a blood borne disease estimated to chronically infect 3% of the
worlds' population causing significant morbidity and mortality. Current medical therapy is …
worlds' population causing significant morbidity and mortality. Current medical therapy is …
[引用][C] Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
J TORRESI, D JOHNSON… - Journal of …, 2011 - pascal-francis.inist.fr
Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
J Torresi, D Johnson… - Journal of …, 2011 - pubmed.ncbi.nlm.nih.gov
Hepatitis C virus (HCV) is a blood borne disease estimated to chronically infect 3% of the
worlds' population causing significant morbidity and mortality. Current medical therapy is …
worlds' population causing significant morbidity and mortality. Current medical therapy is …
Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.
J Torresi, DF Johnson, H Wedemeyer - 2011 - austin.intersearch.com.au
Hepatitis C virus (HCV) is a blood borne disease estimated to chronically infect 3% of the
worlds' population causing significant morbidity and mortality. Current medical therapy is …
worlds' population causing significant morbidity and mortality. Current medical therapy is …
[PDF][PDF] Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
J Torresi, D Johnson, H Wedemeyer - core.ac.uk
HCV infects 3% of the world's population (130 million individuals) and causes an estimated
476,000 deaths per year as a result of HCV-associated end-stage liver disease and its …
476,000 deaths per year as a result of HCV-associated end-stage liver disease and its …
[PDF][PDF] Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
J Torresi, D Johnson, H Wedemeyer - cyberleninka.org
HCV infects 3% of the world's population (130 million individuals) and causes an estimated
476,000 deaths per year as a result of HCV-associated end-stage liver disease and its …
476,000 deaths per year as a result of HCV-associated end-stage liver disease and its …
[HTML][HTML] Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
J Torresi, D Johnson… - Journal of Hepatology, 2011 - journal-of-hepatology.eu
Hepatitis C virus (HCV) is a blood borne disease estimated to chronically infect 3% of the
worlds' population causing significant morbidity and mortality. Current medical therapy is …
worlds' population causing significant morbidity and mortality. Current medical therapy is …
Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.
J Torresi, D Johnson, H Wedemeyer - Journal of Hepatology, 2011 - europepmc.org
Hepatitis C virus (HCV) is a blood borne disease estimated to chronically infect 3% of the
worlds' population causing significant morbidity and mortality. Current medical therapy is …
worlds' population causing significant morbidity and mortality. Current medical therapy is …
Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
J Torresi, D Johnson, H Wedemeyer - Journal of Hepatology, 2011 - infona.pl
Hepatitis C virus (HCV) is a blood borne disease estimated to chronically infect 3% of the
worlds' population causing significant morbidity and mortality. Current medical therapy is …
worlds' population causing significant morbidity and mortality. Current medical therapy is …
Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.
J Torresi, DF Johnson, H Wedemeyer - 2011 - ahro.austin.org.au
Hepatitis C virus (HCV) is a blood borne disease estimated to chronically infect 3% of the
worlds' population causing significant morbidity and mortality. Current medical therapy is …
worlds' population causing significant morbidity and mortality. Current medical therapy is …